Article By:
Benzinga
Saturday, April 17, 2021 6:58 PM EDT
The FDA and CDC announced their recommendation to pause the use of Johnson & Johnson's JNJ COVID-19 vaccine following incidences of severe clots. J&J's pain turned into gains for other COVID-19 vaccine companies.
In this article: ABT, DGX, JNJ, ALNY, BIIB, ISRG, MRNA, PRTA, SNDX, ATXI, ACHL, IKNA, EWTX, DSGN, LVTX